Beyond all the side effects outlined above, there's one specific concern that metformin users may encounter, which could ...

Timing is everything for many things in life — including when to take medication like metformin, sold under the brand names ...

Early metformin initiation after COVID-19 infection is associated with a substantially lower 1-year risk for long COVID in adults with overweight or obesity, according to study results published in ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

The prescription of metformin was associated neither with the development of age-related macular degeneration (AMD) in participants without the condition nor with progression to advanced forms of the ...

A drug that has been prescribed for more than 60 years to manage type 2 diabetes may be working in an unexpected way – through the brain, according to a recent study that could reshape how doctors and ...

The ACIP is scheduled to discuss the hepatitis B vaccine recommended at birth. Ahead of a key meeting amongst the Centers for Disease Control and Prevention (CDC) vaccine advisors -- now with 12 ...

The increasing popularity of weight loss drugs like Wegovy®, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other? How do ...

Metformin, long trusted for diabetes, turns out to work in the brain too. By shutting down Rap1 in the hypothalamus, the drug lowers blood sugar more effectively than previously understood, opening ...

A common and inexpensive diabetes drug could significantly lower the risk of Long COVID in overweight individuals, opening new possibilities for prevention strategies in the pandemic’s long tail.

Metformin, the world’s most widely used diabetes drug, has long been recognized for its surprising range of benefits beyond lowering blood sugar, from reducing inflammation to lowering cancer risk.

Previous research indicated that fotagliptin, a dipeptidyl peptidase 4 inhibitor, provided superior glycemic control than placebo in patients with T2D. Researchers conducted a randomized controlled ...